Insiders · MTEM

Dave Hoffmann

Director at Molecular Templates, Inc. (MTEM)

Dave Hoffmann has filed 5 insider reports with the SEC since June 2021, as director at Molecular Templates, Inc. (MTEM) and director at Durect Corp (DRRX). The latest filing, on September 30, 2024, reports grant or award at Molecular Templates, Inc. (MTEM).

Filings
5
Companies
2
Bought on market
None
Sold on market
None

Companies where Dave Hoffmann is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Molecular Templates, Inc. logo
MTEM
Molecular Templates, Inc.
DirectorSep 30, 2024
Durect Corp logo
DRRX
Durect Corp
DirectorJun 17, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Dave Hoffmann with

Other insiders at the same companies

Questions about Dave Hoffmann

What is Dave Hoffmann's role at Molecular Templates, Inc.?
Dave Hoffmann reports to the SEC as director at Molecular Templates, Inc. (MTEM), according to the latest filing on September 30, 2024. Dave Hoffmann has also filed as director at Durect Corp (DRRX).
Has Dave Hoffmann bought or sold stock recently?
No open-market purchases or sales by Dave Hoffmann are on file. The filings report grant or award.
How do I get alerts when Dave Hoffmann files?
Follow Dave Hoffmann on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Dave Hoffmann (SEC CIK 0001244228). Totals count each trade once, skipping amendments whose original is on file, from Jun 16, 2021 on. View on SEC EDGAR